Author

Roberto Salgado

Peter MacCallum Cancer Centre

Listed by name: these papers carry no ORCID for this author, so different people with the same name may be mixed together.

Biology Disciplines

Click to filter author papers

Genomics· 1 Pathology· 1

Signature Assays, Organisms & Methods

Click to filter · or open tag

Organism:human· 2 Assay:bulk RNA-seq· 1 Research Focus:cell type annotation· 1 Approach:deep learning· 1 Research Focus:differential expression· 1 Research Focus:gene regulatory network inference· 1 Assay:imaging· 1 Approach:statistical model· 1

Frequent Co-Authors

Adam Shlien· 1 shared Anca Mera· 1 shared Anne Lefort· 1 shared Charles MaussioniD· 1 shared Cheryl GillettiD· 1 shared Christine Desmedt· 1 shared Christos Sotiriou· 1 shared David Brown· 1 shared

Activity by Year

2015-2024 · peak 1/yr

Co-Author Collaboration Network

10 top collaborators · 24 mutual co-author links

Click any collaborator node to inspect or filter shared papers

Focal author (center)Selected co-authorORCID co-authorUnlinked name

Curved chords = mutual co-authorship

1 shared paperGenomics

Adam Shlien

Mutual co-authors in cluster

Author profile →

2 papers

Recent·Most cited

Development of a Deep Learning model Tailored for HER2 Detection in Breast Cancer to aid pathologists in interpreting HER2-Low cases

Pierre‐Antoine Bannier, Glenn Broeckx, Loïc Herpin, Rémy Dubois, Lydwine Van Praet, Charles Maussion, Frederik Deman, Ellen Amonoo, Anca Mera, Jasmine Timbres, Cheryl Gillett, Elinor J. Sawyer, Patrycja Gazińska, Piotr P. Ziolkowski, Magali Lacroix‐Triki, , Sheeba Irshad

This paper develops a deep learning model to detect HER2 status in breast cancer, showing higher concordance with ground truth than pathologists for HER2-low cases.

Histopathology · Jul 14, 2024Peer-reviewedPathology

Principles governing A-to-I RNA editing in the breast cancer transcriptome

Debora Fumagalli, David Gacquer, Françoise Rothé, Anne Lefort, Frederick Libert, David Brown, Naima Kheddoumi, Adam Shlien, Tomasz Konopka, Roberto Salgado, Denis Larsimont, Kornelia Polyak, Karen Willard-Gallo, Christine Desmedt, Martine Piccart, , Vincent Detours

This study identifies ADAR expression and inflammation as key regulators of A-to-I RNA editing in breast cancer, showing increased editing frequency in tumors and its impact on cell proliferation and apoptosis.

Cell Reports · Oct 1, 2015Peer-reviewedGenomics